Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

21,977 public trials 3,763 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

NCT05592626

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adenocarcinoma, +91 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • The University of Kansas Cancer Center Kansas City, Kansas, United States
View all 19 locations
View Trial Details
Recruiting

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

NCT07195682

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START-New York Long Island Lake Success, New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Recruiting

A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

NCT05706129

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • UNSW Sydney, St Vincent's Hospital Sydney Sydney, Australia
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges François Leclerc Dijon, France
View Trial Details
Recruiting

PopSci CHW4CervixHealth

NCT07336134

Conditions
Cervical Cancer, Communicable Diseases, DNA Virus Infections, +25 more
Locations
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain

NCT07318688

Conditions
Endometriosis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +3 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Nanjing Women and children's healthcare hospital Nanning, Jiangsu, China
  • Second Affiliated Hospital of Soochow University Suzhu, Jiangsu, China
  • The International Peace Maternity and Child Health Hospital of the China Welfare Institute Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions